» Articles » PMID: 31900523

The Protective Effects of Mogroside V and Its Metabolite 11-oxo-mogrol of Intestinal Microbiota Against MK801-induced Neuronal Damages

Overview
Specialty Pharmacology
Date 2020 Jan 5
PMID 31900523
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Animal models, notably with non-competitive NMDA receptor antagonist MK801, are commonly used to investigate the mechanisms of schizophrenia and to pursue its mechanism-related drug discoveries.

Objectives: In the current study, we have extensively examined the protective effects of MogrosideV (MogV), a plant-derived three terpene glucoside known to exhibit anti-oxidative and anti-inflammatory activities.

Methods And Results: Here, we investigated its protective effects against neuronal damages elicited by MK-801 treatment. Our behavioral experimental results showed that MK-801-induced PPI deficits and social withdrawal were prevented by MogV treatment. Moreover, the cellular and neurochemical responses of MK-801 in medial prefrontal cortical cortex (mPFC) were also ameliorated by MogV treatment. Also, profiling metabolites assay through artificial intestinal microbiota was performed to identify bioactive components of MogV. An in vitro study of primary neuronal culture demonstrated that MogV and its metabolite 11-oxo-mogrol treatment prevented the MK-801-induced neuronal damages through the mechanisms of promoting neurite outgrowth, inhibiting cell apoptosis, and [Ca] release. Additionally, 11-oxo-mogrol reversed inactivation of phosphorylation levels of AKT and mTOR induced by MK801.

Conclusions: These results suggest therapeutic potential of MogV for schizophrenia.

Citing Articles

Mogrol Regulates the Expression of ATPase Na+/K+ Transport Subunit 3, Inhibits Cardiomyocyte Apoptosis, and Plays a Protective Role Against Myocardial Infarction.

Wang F, Zhou J, Liu W, Wang W, Tian B, Liu J Drug Des Devel Ther. 2025; 19:1489-1502.

PMID: 40051467 PMC: 11884411. DOI: 10.2147/DDDT.S490484.


Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action.

Remali J, Aizat W Heliyon. 2024; 10(20):e38986.

PMID: 39640650 PMC: 11620067. DOI: 10.1016/j.heliyon.2024.e38986.


Mogroside V and mogrol: unveiling the neuroprotective and metabolic regulatory roles of in Parkinson's disease.

Tang Q, Qiu R, Guo M, Wang L, Zhang Y, Chen Y Front Pharmacol. 2024; 15:1413520.

PMID: 39108761 PMC: 11300226. DOI: 10.3389/fphar.2024.1413520.


Recent Advances in the Distribution, Chemical Composition, Health Benefits, and Application of the Fruit of .

Guo Q, Shi M, Sarengaowa , Xiao Z, Xiao Y, Feng K Foods. 2024; 13(14).

PMID: 39063362 PMC: 11275593. DOI: 10.3390/foods13142278.


A comprehensive review of (Swingle) C. Jeffrey: chemical composition, pharmacology, toxicology, status of resources development, and applications.

Huang H, Peng Z, Zhan S, Li W, Liu D, Huang S Front Pharmacol. 2024; 15:1388747.

PMID: 38638866 PMC: 11024725. DOI: 10.3389/fphar.2024.1388747.


References
1.
Lin C . Four equivalent sets of mixed-model equations with relationship matrix for estimation of genetic parameters. J Anim Sci. 1988; 66(7):1627-35. DOI: 10.2527/jas1988.6671627x. View

2.
Paulin L, Leheup B, Gueguen R, Deschamps J, PIERSON M . [Evaluation of short stature in boys: delayed growth or constitutional short size?]. Pediatrie. 1989; 44(6):449-54. View

3.
Tambourin P, Casadevall N, Choppin J, Lacombe C, Heard J, Fichelson S . Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc Natl Acad Sci U S A. 1983; 80(20):6269-73. PMC: 394277. DOI: 10.1073/pnas.80.20.6269. View

4.
. British Society of Digestive Endoscopy. Br Med J. 1971; 4(5782):252. PMC: 1799540. View

5.
Muro T, Yuki H, Kawakita T, Chihara Y, Yasumoto M, Setoguchi S . [Syntheses and pharmacological activities of 2-(substituted phenoxymethyl)morpholine derivatives]. Yakugaku Zasshi. 1986; 106(9):764-74. DOI: 10.1248/yakushi1947.106.9_764. View